Schedule 13D ownership disclosure

AVENUE THERAPEUTICS INC

Security class unavailable · CUSIP: 05360L205

Event date: 2022-07-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
10,660,228
Percent of class
46.9500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-083677
Form type
SC 13D
Filer
AVENUE THERAPEUTICS, INC.
CIK
CIK 1644963
Filed
Jul 28, 2022
Reporting period
Jul 25, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub